Endometriosis, fibroid tumors, and menorrhagia are the most common benign conditions affecting the uterus. Products used in the treatment of these disorders include disposable uterine manipulators and hybrid tips, fibroid removal systems, fluid management systems and tubing sets, global endometrial ablation systems, and hysteroscopes and accessories. In 2006, combined sales of these products totaled approximately $415.6 million; over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 16.3%, reaching approximately $760.3 million in the year 2010.

This new report by Medtech Insight presents a detailed overview of the U.S. benign uterine condition management products market. Major topics covered by this report include a description of endometriosis, fibroid tumors, and menorrhagia; procedure volumes for procedures such as dilation and curettage, directed energy-based menorrhagia treatment, fibroid treatment, hysterectomy, and hysteroscopy; and market forecasts for disposable uterine manipulators and hybrid tips, fibroid removal systems, fluid management systems and tubing sets, global endometrial ablation systems, and hysteroscopes and accessories.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i.    Benign Uterine Condition Management

a.   Menorrhagia Treatment

b.   Fibroid Tumor Removal

c.    Resection of Endometriosis

ii.    Products

a.   Uterine Manipulators

b.   Hysteroscopes and Related Products

c.    Global Endometrial Ablation Systems

d.   Fibroid Removal Systems

iii.   Market Analysis

a.   Hysteroscopes and Accessories

b.   Fluid Management Systems

c.    Disposable Uterine Manipulators

d.   Global Endometrial Ablation Systems

e.   Fibroid Removal Systems

Exhibit ES-1:    Benign Uterine Condition Management Products, Combined Market Forecast, 2005-2010

1. BENIGN UTERINE CONDITION MANAGEMENT PRODUCTS

1.1 Menorrhagia

1.2 Fibroid Tumors

1.3 Endometriosis

1.4 Treatment Options

1.4.1 Drug Therapy

1.4.2 Interventions for Menorrhagia

1.4.2.1 Dilation and Curettage

1.4.2.2 Hysterectomy

1.4.2.3 Surgical Endometrial Ablation

1.4.2.3.1 Hysteroscopy

1.4.2.3.2 Ablation Techniques

1.4.2.3.3 Procedures

1.4.2.4 Global Endometrial Ablation

1.4.2.4.1 Hot Water Balloon Systems

1.4.2.4.2 Circulating Heated Saline Systems

1.4.2.4.3 Cryoablation Systems

1.4.2.4.4 Radiofrequency Ablation Systems

1.4.2.4.5 Microwave Ablation Systems

1.4.2.4.6 Laser-Based Systems

1.4.2.4.7 Levonorgestrel-Releasing Intrauterine System

1.4.2.4.8 Procedures

1.4.3 Fibroid Removal

1.4.3.1 Myomectomy

1.4.3.1.1 Open Myomectomy

1.4.3.1.2 Laparoscopic Myomectomy

1.4.3.1.3 Hysteroscopic Resection

1.4.3.2 Myolysis and Cryomyolysis

1.4.3.3 Transcatheter Uterine Artery Embolization

1.4.3.4 High-Intensity Focused Ultrasound

1.4.3.5 Radiofrequency

1.4.3.6 Drug Therapy

1.4.3.7 Procedures

1.4.4 Resection of Endometriosis

1.4.4.1 Current Surgical Options

1.4.4.2 Photodynamic Therapy

1.4.4.3 Drug Therapy

1.5 Products

1.5.1 Uterine Manipulators

1.5.2 Hysteroscopes and Related Products

1.5.2.1 Hysteroscopes

1.5.2.1.1 CooperSurgical/The Cooper Companies

1.5.2.1.2 Gynecare/Johnson & Johnson

1.5.2.1.3 Gyrus ACMI/Gyrus Group

1.5.2.1.4 Olympus America/Olympus

1.5.2.1.5 KARL STORZ Endoscopy-America/KARL STORZ

1.5.2.1.6 Richard Wolf Medical Instruments/Richard Wolf

1.5.2.2 Fluid Management Systems

1.5.2.2.1 Davol/C.R. Bard

1.5.2.2.2 Gynecare/Johnson & Johnson

1.5.2.2.3 Olympus America/Olympus

1.5.2.2.4 Richard Wolf Medical Instruments/Richard Wolf

1.5.3 Global Endometrial Ablation Systems

1.5.3.1 American Medical Systems

1.5.3.2 Boston Scientific

1.5.3.3 Gynecare/Johnson & Johnson

1.5.3.4 Cytyc/Hologic

1.5.3.5 Microsulis

1.5.3.6 Pnn Medical

1.5.4 Fibroid Removal Systems

1.5.4.1 Uterine Artery Embolization Systems

1.5.4.1.1 BioSphere Medical

1.5.4.1.2 Boston Scientific

1.5.4.2 High-Intensity Focused Ultrasound

1.5.4.2.1 InSightec

1.5.4.3 Transurethral Needle Ablation Systems

1.6 Market Analysis

1.6.1 Hysteroscopy Systems and Accessories

1.6.1.1 Competitive Analysis

1.6.2 Fluid Management Products

1.6.2.1 Competitive Analysis

1.6.3 Disposable Uterine Manipulators

1.6.3.1 Competitive Analysis

1.6.4 Global Endometrial Ablation Systems

1.6.4.1 Competitive Analysis

1.6.5 Fibroid Removal Systems

Exhibit 1-1:      Distribution of Endometrial Tissue within the Pelvic Area, by Location

Exhibit 1-2:      Stages of Endometriosis

Exhibit 1-3:      Dilation and Curettage, Procedure Volumes Forecast, 2005-2010

Exhibit 1-4:      Hysterectomy, Procedure Volumes Forecast, 2005-2010

Exhibit 1-5:      Operative Hysteroscopy, Procedure Volumes Forecast, 2005-2010

Exhibit 1-6:      2007, Comparison of Global Endometrial Ablation Techniques

Exhibit 1-7:      Comparison of Cryoablation and Heat-Based Endometrial Ablation Techniques

Exhibit 1-8:      Global Endometrial Ablation for Menorrhagia, Procedure Volumes Forecast, 2005-2010

Exhibit 1-9:      2007, Comparison of Fibroid Removal Techniques

Exhibit 1-10:    Comparison of Laparoscopic and Open Myomectom

Exhibit 1-11:    Fibroid Treatment, Procedure Volumes Forecast, 2005-2010

Exhibit 1-12:    2007, Comparison of Uterine Manipulators

Exhibit 1-13:    2007, Selected Hysteroscopes

Exhibit 1-14:    2007, Selected Fluid Management Systems

Exhibit 1-15:    2007, Selected Global Endometrial Ablation Systems

Exhibit 1-16:    Comparison of THERMACHOICE and Rollerball Ablation

Exhibit 1-17:    2007, Selected Embolic Agents

Exhibit 1-18:    Benign Uterine Condition Management Products, Combined Market Forecast, 2005-2010

Exhibit 1-19:    Hysteroscopes and Accessories, Market Forecast, 2005-2010

Exhibit 1-20:    2006, Hysteroscopes Market, Share by Supplier

Exhibit 1-21:    2006, Hysteroscope Electrode Accessories Market, Share by Supplier

Exhibit 1-22:    Fluid Management and Tubing Sets, Market Forecast, 2005-2010

Exhibit 1-23:    2006, Fluid Management Systems and Tubing Sets Market, Share by Supplier

Exhibit 1-24:    Disposable Uterine Manipulators and Hybrid Tips, Market Forecast, 2005-2010

Exhibit 1-25:    2006, Disposable Uterine Manipulators and Hybrid Tips Market, Share by Supplier

Exhibit 1-26:    Directed Energy-Based Global Endometrial Ablation Systems, Market Forecast, 2005-2010

Exhibit 1-27:    2006, Directed Energy-Based Global Endometrial Ablation Systems Market, Share by Supplier

Exhibit 1-28:    Fibroid Removal Systems, Market Forecast, 2005-2010

2. COMPANY PROFILES

2.1       American Medical Systems, Inc.

2.2       C.R. Bard, Inc.

2.3       Boston Scientific Corporation

2.4       CooperSurgical, Inc./The Cooper Companies, Inc.

2.5       Cytyc Corporation/Hologic, Inc.

2.6       Johnson & Johnson

2.7       Microsulis Medical LTD

2.8       Olympus America, Inc./Olympus Corporation

2.9       KARL STORZ Endoscopy-America, Inc./KARL STORZ GmbH & Company KG

2.10     Richard Wolf Medical Instruments Corporation/Richard Wolf GmbH